FARE - Food Allergy Research & Education Logo
Media Room May 10, 2022

FARE Celebrates 10 Years of Generous Giving

May 10, 2022 (McLean, VA) – Food Allergy Research & Education (FARE) has spent the past ten years educating, advocating, researching and raising much-needed funds for the food allergy community. Today, on Living Teal Food Allergy Awareness Week’s ‘Giving Tuesday,’ FARE recognizes and celebrates the generosity of our donors. Without them, FARE would not be the success story we are today. 

FARE’s diverse consortium of stakeholders--from patients and doctors to elected officials, college cafeterias, researchers and beyond--has raised over $100 million to support critical research in the food allergy community.

With the valuable support of donors, FARE helped fund the launch of Aimmune, a biotech company focused solely on food allergies which has produced an FDA approved drug. Innovative breakthroughs like this can’t happen without the assistance of generous individuals and corporations. 

Of special note, FARE’s 10th Anniversary Co-Chair, Adam Miller, recently pledged $1 million to further research in the food allergy space. Adam has long been an advocate in the food allergy community, having led the merger of Food Allergy & Anaphylaxis Network (FAAN) and Food Allergy Initiative (FAI) to create FARE. He also seeded Aimmune with fellow FARE Board Member Dave Bunning and helped build the UCLA Food Allergy Program in Los Angeles. 

If you would like to help make a difference in the lives of our food allergic friends and family, please consider donating today

For more information, please visit www.foodallergy.org

Media Contact: 


About FARE

FARE (Food Allergy Research and Education) is the nation’s leading non-profit engaged in food allergy advocacy as well as the largest private funder of food allergy research. FARE’s innovative education, advocacy and research initiatives transform the future of food allergy through new and improved treatments and prevention strategies, effective policies and legislation, and novel approaches to managing the disease. To learn more, visit: foodallergy.org.

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.